Crossmark Global Holdings’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,108
| Closed | -$12K | – | 1326 |
|
|
2023
Q1 | $12K | Hold |
1,108
| – | – | ﹤0.01% | 1294 |
|
|
2022
Q4 | $38K | Hold |
1,108
| – | – | ﹤0.01% | 1250 |
|
|
2022
Q3 | $53K | Sell |
1,108
-12
| -1% | -$574 | ﹤0.01% | 1236 |
|
|
2022
Q2 | $63K | Sell |
1,120
-176
| -14% | -$9.9K | ﹤0.01% | 1267 |
|
|
2022
Q1 | $104K | Buy |
1,296
+25
| +2% | +$2.01K | ﹤0.01% | 1331 |
|
|
2021
Q4 | $258K | Buy |
1,271
+156
| +14% | +$31.7K | 0.01% | 1221 |
|
|
2021
Q3 | $300K | Buy |
1,115
+7
| +0.6% | +$1.88K | 0.01% | 1168 |
|
|
2021
Q2 | $285K | Buy |
1,108
+86
| +8% | +$22.1K | 0.01% | 1206 |
|
|
2021
Q1 | $307K | Buy |
1,022
+6
| +0.6% | +$1.8K | 0.01% | 1160 |
|
|
2020
Q4 | $259K | Buy |
1,016
+10
| +1% | +$2.55K | 0.01% | 1172 |
|
|
2020
Q3 | $250K | Buy |
1,006
+7
| +0.7% | +$1.74K | 0.01% | 1111 |
|
|
2020
Q2 | $347K | Buy |
999
+67
| +7% | +$23.3K | 0.01% | 935 |
|
|
2020
Q1 | $250K | Sell |
932
-41
| -4% | -$11K | 0.01% | 945 |
|
|
2019
Q4 | $315K | Buy |
973
+81
| +9% | +$26.2K | 0.01% | 1092 |
|
|
2019
Q3 | $244K | Sell |
892
-58
| -6% | -$15.9K | 0.01% | 1165 |
|
|
2019
Q2 | $507K | Buy |
950
+20
| +2% | +$10.7K | 0.01% | 804 |
|
|
2019
Q1 | $468K | Buy |
930
+20
| +2% | +$10.1K | 0.01% | 848 |
|
|
2018
Q4 | $448K | Sell |
910
-270
| -23% | -$133K | 0.01% | 812 |
|
|
2018
Q3 | $1.08M | Sell |
1,180
-1
| -0.1% | -$914 | 0.03% | 578 |
|
|
2018
Q2 | $865K | Buy |
1,181
+251
| +27% | +$184K | 0.02% | 661 |
|
|
2018
Q1 | $1.48M | Sell |
930
-1,081
| -54% | -$1.72M | 0.04% | 497 |
|
|
2017
Q4 | $1.8M | Buy |
2,011
+55
| +3% | +$49.3K | 0.04% | 458 |
|
|
2017
Q3 | $704K | Buy |
+1,956
| New | +$704K | 0.02% | 766 |
|
|
2016
Q3 | $704K | Buy |
+1,956
| New | +$704K | 0.02% | 766 |
|